000 | 01045 a2200337 4500 | ||
---|---|---|---|
005 | 20250513140007.0 | ||
264 | 0 | _c19980409 | |
008 | 199804s 0 0 eng d | ||
022 | _a0022-5347 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPannek, J | |
245 | 0 | 0 |
_aThe use of percent free prostate specific antigen for staging clinically localized prostate cancer. _h[electronic resource] |
260 |
_bThe Journal of urology _cApr 1998 |
||
300 |
_a1238-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aRittenhouse, H G | |
700 | 1 | _aChan, D W | |
700 | 1 | _aEpstein, J I | |
700 | 1 | _aWalsh, P C | |
700 | 1 | _aPartin, A W | |
773 | 0 |
_tThe Journal of urology _gvol. 159 _gno. 4 _gp. 1238-42 |
|
999 |
_c9475666 _d9475666 |